Is Abbott Stock Undervalued At $95?

Abbott (NYSE: ABT) reported its Q3 results last week, with revenues and earnings beating the street estimates.

Related Keywords

,Health Care ,Trefis High Quality Portfolio ,Medical Device ,Established Pharmaceuticals ,S Ampp 500 ,Hq Portfolio ,Abbott Stock ,Abt Stock ,Abt Revenue ,Abbott ,Covid 19 ,Diagnostics ,Medical Devices ,Abt Q3 ,